Filings
Finds words inside filing documents. Searching Pacira BioSciences, Inc.'s filings · 33 documents indexed.
19 documents · 82 matches
-
PCRX Pacira BioSciences, Inc. 10-K 2026-02-26
Item 1A. Risk Factors
tariff on Swiss origin goods—including branded pharmaceuticals—and likewise exempting Switzerland from potential higher tariffs under the same Section22 matches in this document -
PCRX Pacira BioSciences, Inc. 10-Q 2026-08-04
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Tariff Schedule (HTS) U.S. codes listed in Annex I. The Presidential Order imposes country-specific tariffs, including 15% tariffs on certain10 matches in this document -
PCRX Pacira BioSciences, Inc. 10-Q 2026-04-30
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Tariff Schedule (HTS) U.S. codes listed in Annex I. The Presidential Order imposes country-specific tariffs, including 15% tariffs on certain10 matches in this document -
PCRX Pacira BioSciences, Inc. 10-Q 2025-11-06
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariff on most imports from the E.U., including branded pharmaceuticals, and effectively exempts the E.U. from higher tariffs that may be imposed9 matches in this document -
PCRX Pacira BioSciences, Inc. 10-Q 2026-11-05
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs to date, the current macroeconomic environment remains dynamic and subject to rapid and potentially material change. Our business may be adversely9 matches in this document -
PCRX Pacira BioSciences, Inc. 10-Q 2025-08-05
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs impacting our industry, the magnitude of response by other countries to such tariffs and the length of time such7 matches in this document -
PCRX Pacira BioSciences, Inc. 10-Q 2025-05-08
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs, which could, among other things, result in higher costs for labor, raw materials, equipment and other goods and services3 matches in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-11-05
Item 7.01. Regulation FD Disclosure.
tariffs and trade restrictions, inflation rates, interest rates and global exchange rates; and inherent uncertainties involved in the estimates and judgments1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-10-08
Item 7.01. Regulation FD Disclosure.
tariffs and trade restrictions, inflation rates, interest rates and global exchange rates; and inherent uncertainties involved in the estimates and judgments1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-10-08
tariffs and trade restrictions, inflation rates, interest rates and global exchange rates; and inherent uncertainties involved in the estimates and judgments1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-08-04
tariffs, inflation and rising interest rates), and our business, including our revenues, financial condition, cash flows and results of operations1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-06-30
tariffs, inflation and rising interest rates), and our business, including our revenues, financial condition, cash flows and results of operations1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-06-11
tariffs, inflation and rising interest rates), and our business, including our revenues, financial condition, cash flows and results of operations1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-04-30
tariffs, inflation and rising interest rates), and our business, including our revenues, financial condition, cash flows and results of operations1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-02-26
tariffs, inflation and rising interest rates), and our business, including our revenues, financial condition, cash flows and results of operations1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-01-28
tariffs, inflation and rising interest rates), and our business, including our revenues, financial condition, cash flows and results of operations1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2026-01-08
tariffs, inflation and rising interest rates), and our business, including our revenues, financial condition, cash flows and results of operations1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2025-11-06
tariffs, inflation and rising interest rates), and our business, including our revenues, financial condition, cash flows and results of operations1 match in this document -
PCRX Pacira BioSciences, Inc. 8-K 2025-08-05
tariffs, inflation and rising interest rates), and our business, including our revenues, financial condition, cash flows and results of operations1 match in this document
Page 1 of 1 · 19 documents